You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華東醫藥(000963.SZ)終止收購佐力藥業(300181.SZ)股份
格隆匯 10-20 19:58

格隆匯10月20日丨華東醫藥(000963.SZ)公佈,公司於2019年5月24日與深圳證券交易所創業板上市公司浙江佐力藥業股份有限公司控股股東俞有強及股東德清縣烏靈股權投資合夥企業(有限合夥)簽署了《股份轉讓意向書》。

目前公司未與轉讓方簽訂正式的股份轉讓協議,終止本次交易是公司審慎研究並與轉讓方協商一致的結果。各方同意自本終止協議生效之日起原《股份轉讓意向書》終止,原《股份轉讓意向書》除“保密條款”外,其他條款對各方均不再有法律約束力,各方互不承擔違約責任。股權轉讓方在本終止協議生效之日起五日內協助公司釋放已支付入共管賬户中的5000萬元誠意金。

公司稱,終止本次交易不會對公司業績及生產經營產生不利影響,也不會對公司今後戰略目標的實現帶來實質性障礙,亦不存在損害公司及全體股東利益的情形。公司將繼續堅持戰略轉型和高質量發展的總體目標,進一步推進國際化發展戰略,努力做好各項經營管理工作,持續提升經營業績,切實維護廣大股東利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account